Product Details
Octreotide for Injectable Suspension
Octreotide20 mg
Powder for Injectable Suspension
Vial + Diluent in Prefilled Syringe Kit
DIN/PIN/NPN
02503778
Manufacturer
Teva Canada Limited
Formulary Listing Date
2021-11-30
Unit Price
1279.9350
Amount MOH Pays
1279.9350
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
H01CB02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02239324 | Sandostatin LAR | 1706.5800 | 1279.9350 |
| 02503778 | Octreotide for Injectable Suspension | 1279.9350 | 1279.9350 |